Petros Pharmaceuticals Inc (PTPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,385 | -20,038 | -15,816 | -1,986 | -174 |
| Depreciation Amortization | 858 | 13,176 | 12,143 | 3,122 | 1,561 |
| Accounts receivable | -326 | 516 | -1,174 | -3,186 | -1,170 |
| Accounts payable and accrued liabilities | 52 | -2,752 | -2,474 | -2,653 | -858 |
| Other Working Capital | -439 | -3,091 | -4,638 | -7,354 | -3,084 |
| Other Operating Activity | 491 | -609 | 732 | 2,582 | -1,550 |
| Operating Cash Flow | $-748 | $-12,797 | $-11,227 | $-9,476 | $-5,276 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -358 | -1,624 | -1,439 | -1,077 | -900 |
| Financing Cash Flow | $-358 | $-1,624 | $-1,439 | $-1,077 | $-900 |
| Beginning Cash Position | 9,426 | 23,848 | 23,848 | 23,848 | 23,848 |
| End Cash Position | 8,320 | 9,426 | 11,182 | 13,295 | 17,672 |
| Net Cash Flow | $-1,106 | $-14,421 | $-12,666 | $-10,553 | $-6,176 |
| Free Cash Flow | |||||
| Operating Cash Flow | -748 | -12,797 | -11,227 | -9,476 | -5,276 |
| Free Cash Flow | -748 | -12,797 | -11,227 | -9,476 | -5,276 |